Attogenix Biosystems
From Wikipedia, the free encyclopedia
 |
This article needs sources or references that appear in reliable, third-party publications. Primary sources and sources affiliated with the subject of the article are generally not sufficient for a Wikipedia article. Please include more appropriate citations from reliable sources, or discuss the issue on the talk page. This article has been tagged since September 2007. |
| This article may not meet the notability guidelines for companies and organizations. If you are familiar with the subject matter, please expand or rewrite the article to establish its notability. The best way to address this concern is to reference published, third-party sources about the subject. If notability cannot be established, the article is more likely to be considered for redirection, merge or ultimately deletion, per Wikipedia:Guide to deletion. This article has been tagged since September 2007. |
Attogenix Biosystems Pte Ltd is a Singapore biotechnology company.
Founded in 2002, as a spin-off from Nanyang Technological University and the DSO National Laboratories, the company's product focus is on nucleic acid testing platforms with emphasis on infectious disease detection (such as dengue fever, SARS), genome profiling and applications for countering bioterrorism.
[edit] Dengue diagnostic kits
In 2005, the company developed a biochip called AttoChip which has successfully undergone an independent clinical trial conducted by Tan Tock Seng Hospital and is 98 percent accurate. The AttoChip identifies genes, viruses and bacteria-causing diseases from a blood sample. It can detect the presence of the dengue virus within two to three days of the onset of the virus. [1][2]
